Q3 2022 EPS Estimates for Addus HomeCare Co. Cut by Oppenheimer (NASDAQ:ADUS)

Addus HomeCare Co. (NASDAQ:ADUSGet Rating) – Research analysts at Oppenheimer dropped their Q3 2022 earnings per share estimates for shares of Addus HomeCare in a report issued on Tuesday, August 2nd. Oppenheimer analyst M. Wiederhorn now forecasts that the company will earn $0.80 per share for the quarter, down from their previous estimate of $0.86. Oppenheimer currently has a “Outperform” rating and a $130.00 target price on the stock. The consensus estimate for Addus HomeCare’s current full-year earnings is $3.19 per share.

Several other brokerages have also commented on ADUS. Royal Bank of Canada decreased their price objective on Addus HomeCare from $111.00 to $110.00 and set an “outperform” rating for the company in a report on Wednesday. Stifel Nicolaus began coverage on Addus HomeCare in a research report on Tuesday, June 28th. They issued a “buy” rating and a $101.00 target price on the stock. Stephens cut their target price on Addus HomeCare from $110.00 to $101.00 and set an “overweight” rating on the stock in a research report on Tuesday, June 21st. Finally, Bank of America began coverage on Addus HomeCare in a research report on Wednesday, April 13th. They issued a “buy” rating and a $110.00 target price on the stock. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $110.40.

Addus HomeCare Stock Performance

Shares of ADUS opened at $92.69 on Thursday. Addus HomeCare has a 12 month low of $68.57 and a 12 month high of $108.11. The stock has a fifty day moving average price of $85.97 and a 200-day moving average price of $83.18. The company has a current ratio of 2.00, a quick ratio of 2.65 and a debt-to-equity ratio of 0.33. The firm has a market cap of $1.49 billion, a PE ratio of 33.58, a P/E/G ratio of 2.62 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUSGet Rating) last issued its quarterly earnings data on Monday, August 1st. The company reported $0.91 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.01). Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The business had revenue of $236.94 million for the quarter, compared to analysts’ expectations of $238.40 million. During the same quarter in the prior year, the company posted $0.78 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis.

Insiders Place Their Bets

In other Addus HomeCare news, EVP David W. Tucker sold 2,080 shares of the stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $90.00, for a total transaction of $187,200.00. Following the sale, the executive vice president now directly owns 8,468 shares of the company’s stock, valued at approximately $762,120. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 1,718 shares of the stock in a transaction dated Tuesday, May 24th. The stock was sold at an average price of $85.00, for a total transaction of $146,030.00. Following the sale, the executive vice president now directly owns 7,012 shares of the company’s stock, valued at approximately $596,020. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP David W. Tucker sold 2,080 shares of the stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $90.00, for a total value of $187,200.00. Following the sale, the executive vice president now directly owns 8,468 shares in the company, valued at $762,120. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,940 shares of company stock valued at $344,102. Company insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Seizert Capital Partners LLC acquired a new stake in Addus HomeCare during the 2nd quarter worth about $1,552,000. Envestnet Asset Management Inc. boosted its stake in shares of Addus HomeCare by 79.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 16,078 shares of the company’s stock worth $1,339,000 after acquiring an additional 7,140 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Addus HomeCare by 110.1% during the 2nd quarter. Assetmark Inc. now owns 374 shares of the company’s stock worth $31,000 after acquiring an additional 196 shares in the last quarter. US Bancorp DE boosted its stake in shares of Addus HomeCare by 11.4% during the 2nd quarter. US Bancorp DE now owns 4,172 shares of the company’s stock worth $347,000 after acquiring an additional 428 shares in the last quarter. Finally, Argent Capital Management LLC boosted its stake in shares of Addus HomeCare by 3.1% during the 2nd quarter. Argent Capital Management LLC now owns 7,295 shares of the company’s stock worth $608,000 after acquiring an additional 222 shares in the last quarter. 96.04% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Earnings History and Estimates for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.